Single Nucleotide <i>SMN1</i> Variants in a Cohort of Individuals With Spinal Muscular Atrophy. [PDF]
Rimoldi M +11 more
europepmc +1 more source
Evaluating Therapeutic Outcomes in Spinal Muscular Atrophy: An Indian Experience. [PDF]
Mohanlal S +8 more
europepmc +1 more source
Genetic risk assessment in carrier testing for spinal muscular atrophy [PDF]
Shuji Ogino +4 more
openalex +1 more source
Safety through design: Expanding options for spinal muscular atrophy gene therapy. [PDF]
Groen EJN, Wadman RI.
europepmc +1 more source
Physical capacity in non‐ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study [PDF]
Birgit F. Steffensen +4 more
openalex +1 more source
The Effect of Aerobic Exercise Training on Patients with Type III Spinal Muscular Atrophy. [PDF]
Mergen Kilic S +9 more
europepmc +1 more source
Administration of Onasemnogene Abeparvovec in an Infant With Spinal Muscular Atrophy and PCR-Confirmed SARS-CoV-2 Infection. [PDF]
Shimomura I +4 more
europepmc +1 more source
Correlation between Genotype and Phenotype in Korean Patients with Spinal Muscular Atrophy
Kyounam Cho +6 more
openalex +1 more source
Cerebellar defects are a primary pathology in mouse models of spinal muscular atrophy. [PDF]
Cottam NC +9 more
europepmc +1 more source

